Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive neoplastic disorder in which chemotherapy resistance and refractory relapses occur, with a poorer prognostic outcome. Constitutively active PI3K/Akt/mTOR pathway is a common feature of T-ALL upregulating cell proliferation, survival and dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cani, Alice, Simioni, Carolina, Martelli, Alberto M., Zauli, Giorgio, Tabellini, Giovanna, Ultimo, Simona, McCubrey, James A., Capitani, Silvano, Neri, Luca M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466637/
https://www.ncbi.nlm.nih.gov/pubmed/25788264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466637/
https://www.ncbi.nlm.nih.gov/pubmed/25788264

Ejemplares similares